Anne Samuel
Stock Analyst at JP Morgan
(3.65)
# 893
Out of 4,435 analysts
32
Total ratings
50%
Success rate
8.2%
Average return
Main Sectors:
13 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PINC Premier | Maintains: Neutral | $23 → $21 | $18.92 | +10.99% | 3 | May 28, 2024 | |
| DOCS Doximity | Upgrades: Neutral | $25 | $27.73 | -9.84% | 3 | Apr 25, 2024 | |
| HQY HealthEquity | Maintains: Overweight | $86 → $108 | $81.68 | +32.22% | 4 | Apr 2, 2024 | |
| EVH Evolent Health | Maintains: Overweight | $53 → $52 | $21.19 | +145.40% | 3 | Mar 15, 2024 | |
| VEEV Veeva Systems | Maintains: Neutral | $183 → $222 | $174.25 | +27.40% | 3 | Mar 13, 2024 | |
| RCM R1 RCM | Downgrades: Neutral | $20 → $11 | $12.86 | -14.46% | 3 | Dec 13, 2023 | |
| MODN Model N | Downgrades: Neutral | $30 → $25 | $29.89 | -16.36% | 1 | Dec 13, 2023 | |
| HCAT Health Catalyst | Upgrades: Overweight | $14 → $11 | $6.63 | +65.91% | 2 | Dec 13, 2023 | |
| IQV IQVIA Holdings | Maintains: Overweight | $262 → $239 | $219.09 | +9.09% | 2 | Nov 13, 2023 | |
| PGNY Progyny | Maintains: Overweight | $58 → $57 | $26.95 | +111.50% | 3 | Oct 9, 2023 | |
| CCSI Consensus Cloud Solutions | Maintains: Neutral | $51 → $41 | $18.87 | +117.28% | 2 | May 15, 2023 | |
| OMCL Omnicell | Maintains: Neutral | $140 → $57 | $32.59 | +74.90% | 2 | Nov 18, 2022 | |
| MDRX Veradigm | Maintains: Underweight | $19 → $20 | $9.50 | +110.53% | 1 | Nov 18, 2022 |
Premier
May 28, 2024
Maintains: Neutral
Price Target: $23 → $21
Current: $18.92
Upside: +10.99%
Doximity
Apr 25, 2024
Upgrades: Neutral
Price Target: $25
Current: $27.73
Upside: -9.84%
HealthEquity
Apr 2, 2024
Maintains: Overweight
Price Target: $86 → $108
Current: $81.68
Upside: +32.22%
Evolent Health
Mar 15, 2024
Maintains: Overweight
Price Target: $53 → $52
Current: $21.19
Upside: +145.40%
Veeva Systems
Mar 13, 2024
Maintains: Neutral
Price Target: $183 → $222
Current: $174.25
Upside: +27.40%
R1 RCM
Dec 13, 2023
Downgrades: Neutral
Price Target: $20 → $11
Current: $12.86
Upside: -14.46%
Model N
Dec 13, 2023
Downgrades: Neutral
Price Target: $30 → $25
Current: $29.89
Upside: -16.36%
Health Catalyst
Dec 13, 2023
Upgrades: Overweight
Price Target: $14 → $11
Current: $6.63
Upside: +65.91%
IQVIA Holdings
Nov 13, 2023
Maintains: Overweight
Price Target: $262 → $239
Current: $219.09
Upside: +9.09%
Progyny
Oct 9, 2023
Maintains: Overweight
Price Target: $58 → $57
Current: $26.95
Upside: +111.50%
Consensus Cloud Solutions
May 15, 2023
Maintains: Neutral
Price Target: $51 → $41
Current: $18.87
Upside: +117.28%
Omnicell
Nov 18, 2022
Maintains: Neutral
Price Target: $140 → $57
Current: $32.59
Upside: +74.90%
Veradigm
Nov 18, 2022
Maintains: Underweight
Price Target: $19 → $20
Current: $9.50
Upside: +110.53%